BiomX Inc (PHGE)
0.42
-0.02
(-5.53%)
USD |
NYAM |
May 02, 13:41
BiomX Enterprise Value: 20.83M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 20.83M |
| April 30, 2024 | 22.73M |
| April 29, 2024 | 17.25M |
| April 26, 2024 | 15.61M |
| April 25, 2024 | 14.83M |
| April 24, 2024 | 15.05M |
| April 23, 2024 | 15.41M |
| April 22, 2024 | 12.58M |
| April 19, 2024 | 12.29M |
| April 18, 2024 | 12.61M |
| April 17, 2024 | 11.75M |
| April 16, 2024 | 11.76M |
| April 15, 2024 | 12.85M |
| April 12, 2024 | 13.67M |
| April 11, 2024 | 14.24M |
| April 10, 2024 | 15.14M |
| April 09, 2024 | 15.66M |
| April 08, 2024 | 16.04M |
| April 05, 2024 | 17.25M |
| April 04, 2024 | 17.26M |
| April 03, 2024 | 15.61M |
| April 02, 2024 | 17.50M |
| April 01, 2024 | 18.89M |
| March 28, 2024 | 21.13M |
| March 27, 2024 | 12.68M |
| Date | Value |
|---|---|
| March 26, 2024 | 11.74M |
| March 25, 2024 | 11.85M |
| March 22, 2024 | 12.03M |
| March 21, 2024 | 12.96M |
| March 20, 2024 | 13.31M |
| March 19, 2024 | 13.32M |
| March 18, 2024 | 12.86M |
| March 15, 2024 | 13.14M |
| March 14, 2024 | 12.91M |
| March 13, 2024 | 14.23M |
| March 12, 2024 | 13.32M |
| March 11, 2024 | 14.10M |
| March 08, 2024 | 15.94M |
| March 07, 2024 | 14.70M |
| March 06, 2024 | 27.96M |
| March 05, 2024 | 6.923M |
| March 04, 2024 | 6.32M |
| March 01, 2024 | 6.074M |
| February 29, 2024 | 5.936M |
| February 28, 2024 | 6.170M |
| February 27, 2024 | 6.510M |
| February 26, 2024 | 5.940M |
| February 23, 2024 | 6.074M |
| February 22, 2024 | 6.442M |
| February 21, 2024 | 6.602M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-21.73M
Minimum
Dec 15 2022
238.59M
Maximum
Feb 18 2020
48.53M
Average
17.26M
Median
Apr 04 2024
Enterprise Value Benchmarks
| Taro Pharmaceutical Industries Ltd | 691.00M |
| InspireMD Inc | 6.802M |
| Alpha Tau Medical Ltd | 91.03M |
| Pluri Inc | 24.07M |
| Raphael Pharmaceutical Inc | 18.43M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.491M |
| Total Expenses (Quarterly) | 5.272M |
| EPS Diluted (Quarterly) | -0.08 |
| Earnings Yield | -126.2% |